Evidence map›Paper›PMID 34183436›Full record

ArticleJournal of clinical pathology2022

Julian Tabasaran, Martin Schuhmann, Martin Ebinger, Jürgen Honegger, Mirjam Renovanz, Jens Schittenhelm

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Julian TabasaranDepartment of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
Martin SchuhmannDepartment of Neurosurgery, Eberhard Karls University of Tuebingen, Baden-Württemberg, Germany.
Martin EbingerDepartment Pediatric Hematology/Oncology, Children's University Hospital, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
Jürgen HoneggerDepartment of Neurosurgery, Eberhard Karls University of Tuebingen, Baden-Württemberg, Germany.
Mirjam RenovanzDepartment of Neurosurgery, Eberhard Karls University of Tuebingen, Baden-Württemberg, Germany.
Jens SchittenhelmDepartment of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany jens.schittenhelm@med.uni-tuebingen.de.ORCID http://orcid.org/0000-0002-9168-6209
University of Tübingen · DEUniversity Children's Hospital Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsAn ependymoma shows divergent morphological and molecular features depending on their location. The paired box 6 (

methodsWe, therefore, analysed

resultsMean

conclusionsWe demonstrate that

Indexed as

Brain NeoplasmsEpendymomaHumansImmunohistochemistryPAX6 Transcription FactorPrognosisTranscription FactorsPAX6 protein, humanPAX6 Transcription FactorTranscription Factorsbrain neoplasmsimmunohistochemistryneuropathology

Identifiers

PMID34183436
PMCPMC9606524
OpenAlexW3174720432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.